+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Preclinical Imaging Market Size, Share & Trends Analysis Report by Product (Devices: CT, MRI, PET/SPECT, Multi-Modal, Optical ), Application (Research & Development, Drug Discovery), End-Use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 120 Pages
  • February 2025
  • Region: Global
  • Grand View Research
  • ID: 3765909
The Preclinical Imaging Market was valued at USD 4.56 billion in 2024, and is projected to reach USD 5.96 billion by 2030, rising at a CAGR of 4.36%. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights

  • The optical imaging segment held the largest revenue share of 13.6% in 2024 owing to their wide usage in small animal imaging and new drug discovery projects.
  • In terms of application, the research & development segment captured the largest revenue share in 2024.
  • The pharma and biotech companies segment captured the largest revenue share of 39.9% in 2024. The demand for pre-clinical imaging in biotech companies has been steadily increasing in recent years and is expected to continue growing in the coming years.
  • North America preclinical imaging market held the largest revenue share of 30.1% in 2024.

This report addresses:

  • Market intelligence to enable effective decision-making.
  • Market estimates and forecasts from 2018 to 2030.
  • Growth opportunities and trend analyses.
  • Segment and regional revenue forecasts for market assessment.
  • Competition strategy and market share analysis.
  • Product innovation listings for you to stay ahead of the curve.
  • COVID-19's impact and how to sustain in this fast-evolving market.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements
3.2.1.2. Growing number of investments and funding in research and development
3.2.2. Market restraint analysis
3.2.2.1. Strict regulatory framework
3.3. Preclinical Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Preclinical Imaging Product Market Movement Analysis
4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. CT
4.4.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
4.5. MRI
4.5.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
4.6. PET/SPECT
4.6.1. PET/SPECT market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Multi Modal
4.7.1. Multi modal market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Optical
4.8.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Ultrasound
4.9.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Photoacoustic
4.10.1. Photoacoustic market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Reagents
4.11.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Services
4.12.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Preclinical Imaging Application Market Movement Analysis
5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Research and Development
5.4.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Drug Discovery
5.5.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Preclinical Imaging End Use Market Movement Analysis
6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharma and Biotech Companies
6.4.1. Pharma and biotech companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Research Institutes
6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End Use
7.1. Regional Market Share Analysis, 2025 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, by Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2025
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders)
8.6. Company Profiles
8.6.1. Bruker Corporation
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Siemens A.G.
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. General Electric (GE)
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. TriFoil Imaging
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. PerkinElmer, Inc.
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. VisualSonics Inc. (Fujifilm)
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Mediso Ltd.
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Agilent Technologies
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. MILabs B.V.
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. MR Solutions
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Molecubes
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America preclinical imaging market, by country, 2018-2030 (USD Million)
Table 3 North America preclinical imaging market, by product, 2018-2030 (USD Million)
Table 4 North America preclinical imaging market, by application, 2018-2030 (USD Million)
Table 5 North America preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 6 U.S. preclinical imaging market, by product, 2018-2030 (USD Million)
Table 7 U.S. preclinical imaging market, by application, 2018-2030 (USD Million)
Table 8 U.S. preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 9 Canada preclinical imaging market, by product, 2018-2030 (USD Million)
Table 10 Canada preclinical imaging market, by application, 2018-2030 (USD Million)
Table 11 Canada preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 12 Mexico preclinical imaging market, by product, 2018-2030 (USD Million)
Table 13 Mexico preclinical imaging market, by application, 2018-2030 (USD Million)
Table 14 Mexico preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 15 Europe preclinical imaging market, by country, 2018-2030 (USD Million)
Table 16 Europe preclinical imaging market, by product, 2018-2030 (USD Million)
Table 17 Europe preclinical imaging market, by application, 2018-2030 (USD Million)
Table 18 Europe preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 19 UK preclinical imaging market, by product, 2018-2030 (USD Million)
Table 20 UK preclinical imaging market, by application, 2018-2030 (USD Million)
Table 21 UK preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 22 Germany preclinical imaging market, by product, 2018-2030 (USD Million)
Table 23 Germany preclinical imaging market, by application, 2018-2030 (USD Million)
Table 24 Germany preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 25 France preclinical imaging market, by product, 2018-2030 (USD Million)
Table 26 France preclinical imaging market, by application, 2018-2030 (USD Million)
Table 27 France preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 28 Italy preclinical imaging market, by product, 2018-2030 (USD Million)
Table 29 Italy preclinical imaging market, by application, 2018-2030 (USD Million)
Table 30 Italy preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 31 Denmark preclinical imaging market, by product, 2018-2030 (USD Million)
Table 32 Denmark preclinical imaging market, by application, 2018-2030 (USD Million)
Table 33 Denmark preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 34 Sweden preclinical imaging market, by product, 2018-2030 (USD Million)
Table 35 Sweden preclinical imaging market, by application, 2018-2030 (USD Million)
Table 36 Sweden preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 37 Norway preclinical imaging market, by product, 2018-2030 (USD Million)
Table 38 Norway preclinical imaging market, by application, 2018-2030 (USD Million)
Table 39 Norway preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 40 Asia Pacific preclinical imaging market, by country, 2018-2030 (USD Million)
Table 41 Asia Pacific preclinical imaging market, by product, 2018-2030 (USD Million)
Table 42 Asia Pacific preclinical imaging market, by application, 2018-2030 (USD Million)
Table 43 Asia Pacific preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 44 Japan preclinical imaging market, by product, 2018-2030 (USD Million)
Table 45 Japan preclinical imaging market, by application, 2018-2030 (USD Million)
Table 46 Japan preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 47 China preclinical imaging market, by product, 2018-2030 (USD Million)
Table 48 China preclinical imaging market, by application, 2018-2030 (USD Million)
Table 49 China preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 50 India preclinical imaging market, by product, 2018-2030 (USD Million)
Table 51 India preclinical imaging market, by application, 2018-2030 (USD Million)
Table 52 India preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 53 Australia preclinical imaging market, by product, 2018-2030 (USD Million)
Table 54 Australia preclinical imaging market, by application, 2018-2030 (USD Million)
Table 55 Australia preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 56 South Korea preclinical imaging market, by product, 2018-2030 (USD Million)
Table 57 South Korea preclinical imaging market, by application, 2018-2030 (USD Million)
Table 58 South Korea preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 59 Thailand preclinical imaging market, by product, 2018-2030 (USD Million)
Table 60 Thailand preclinical imaging market, by application, 2018-2030 (USD Million)
Table 61 Thailand preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 62 Latin America preclinical imaging market, by Country, 2018-2030 (USD Million)
Table 63 Latin America preclinical imaging market, by product, 2018-2030 (USD Million)
Table 64 Latin America preclinical imaging market, by application, 2018-2030 (USD Million)
Table 65 Latin America preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 66 Brazil preclinical imaging market, by product, 2018-2030 (USD Million)
Table 67 Brazil preclinical imaging market, by application, 2018-2030 (USD Million)
Table 68 Brazil preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 69 Argentina preclinical imaging market, by product, 2018-2030 (USD Million)
Table 70 Argentina preclinical imaging market, by application, 2018-2030 (USD Million)
Table 71 Argentina preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 72 Middle East & Africa preclinical imaging market, by country, 2018-2030 (USD Million)
Table 73 Middle East & Africa preclinical imaging market, by product, 2018-2030 (USD Million)
Table 74 Middle East & Africa preclinical imaging market, by application, 2018-2030 (USD Million)
Table 75 Middle East & Africa preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 76 South Africa preclinical imaging market, by product, 2018-2030 (USD Million)
Table 77 South Africa preclinical imaging market, by application, 2018-2030 (USD Million)
Table 78 South Africa preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 79 Saudi Arabia preclinical imaging market, by product, 2018-2030 (USD Million)
Table 80 Saudi Arabia preclinical imaging market, by application, 2018-2030 (USD Million)
Table 81 Saudi Arabia preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 82 UAE preclinical imaging market, by product, 2018-2030 (USD Million)
Table 83 UAE preclinical imaging market, by application, 2018-2030 (USD Million)
Table 84 UAE preclinical imaging market, by end use, 2018-2030 (USD Million)
Table 85 Kuwait preclinical imaging market, by product, 2018-2030 (USD Million)
Table 86 Kuwait preclinical imaging market, by application, 2018-2030 (USD Million)
Table 87 Kuwait preclinical imaging market, by end use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Dermatology imaging devices market: Market outlook
Figure 14 Dermatology imaging devices market competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Penetration and growth prospect mapping
Figure 18 Industry value chain analysis
Figure 19 Preclinical imaging market driver impact
Figure 20 Preclinical imaging restraint impact
Figure 21 Preclinical imaging market: product movement analysis
Figure 22 Preclinical imaging market: product outlook and key takeaways
Figure 23 CT market estimates and forecast, 2018-2030
Figure 24 MRI market estimates and forecast, 2018-2030
Figure 25 PET/SPECT market estimates and forecast, 2018-2030
Figure 26 Multi Modal market estimates and forecast, 2018-2030
Figure 27 Optical market estimates and forecast, 2018-2030
Figure 28 Ultrasound market estimates and forecast, 2018-2030
Figure 29 Photoacoustic market estimates and forecast, 2018-2030
Figure 30 Reagents market estimates and forecast, 2018-2030
Figure 31 Services market estimates and forecast, 2018-2030
Figure 32 Preclinical imaging market: application movement analysis
Figure 33 Preclinical imaging market: application outlook and key takeaways
Figure 34 Research and development market estimates and forecast, 2018-2030
Figure 35 Drug discovery market estimates and forecast, 2018-2030
Figure 36 Preclinical imaging market: end use movement analysis
Figure 37 Preclinical imaging market: end use outlook and key takeaways
Figure 38 Pharma and biotech companies market estimates and forecast, 2018-2030
Figure 39 Research institutes market estimates and forecast, 2018-2030
Figure 40 Global Dermatology imaging devices market: regional movement analysis
Figure 41 Global Dermatology imaging devices market: regional outlook and key takeaways
Figure 42 North America
Figure 43 North America market estimates and forecast, 2018-2030
Figure 44 U.S.
Figure 45 U.S. market estimates and forecast, 2018-2030
Figure 46 Canada
Figure 47 Canada market estimates and forecast, 2018-2030
Figure 48 Mexico
Figure 49 Mexico market estimates and forecast, 2018-2030
Figure 50 Europe
Figure 51 Europe. market estimates and forecast, 2018-2030
Figure 52 UK
Figure 53 UK market estimates and forecast, 2018-2030
Figure 54 Germany
Figure 55 Germany market estimates and forecast, 2018-2030
Figure 56 France
Figure 57 France market estimates and forecast, 2018-2030
Figure 58 Italy
Figure 59 Italy market estimates and forecast, 2018-2030
Figure 60 Spain
Figure 61 Spain market estimates and forecast, 2018-2030
Figure 62 Denmark
Figure 63 Denmark market estimates and forecast, 2018-2030
Figure 64 Sweden
Figure 65 Sweden market estimates and forecast, 2018-2030
Figure 66 Norway
Figure 67 Norway market estimates and forecast, 2018-2030
Figure 68 Asia Pacific
Figure 69 Asia Pacific market estimates and forecast, 2018-2030
Figure 70 Japan
Figure 71 Japan market estimates and forecast, 2018-2030
Figure 72 China
Figure 73 China market estimates and forecast, 2018-2030
Figure 74 India
Figure 75 India market estimates and forecast, 2018-2030
Figure 76 South Korea
Figure 77 South Korea market estimates and forecast, 2018-2030
Figure 78 Thailand
Figure 79 Thailand market estimates and forecast, 2018-2030
Figure 80 Australia
Figure 81 Australia market estimates and forecast, 2018-2030
Figure 82 Latin America
Figure 83 Latin America market estimates and forecast, 2018-2030
Figure 84 Brazil
Figure 85 Brazil market estimates and forecast, 2018-2030
Figure 86 Argentina
Figure 87 Argentina market estimates and forecast, 2018-2030
Figure 88 Middle East and Africa
Figure 89 Middle East and Africa. market estimates and forecast, 2018-2030
Figure 90 Saudi Arabia
Figure 91 Saudi Arabia market estimates and forecast, 2018-2030
Figure 92 South Africa
Figure 93 South Africa market estimates and forecast, 2018-2030
Figure 94 UAE
Figure 95 UAE market estimates and forecast, 2018-2030
Figure 96 Kuwait
Figure 97 Kuwait market estimates and forecast, 2018-2030
Figure 98 Participant categorization- Preclinical imaging market
Figure 99 Market share of key market players- Preclinical imaging market

Companies Mentioned

The major companies profiled in this Preclinical Imaging market report include:
  • Bruker Corporation,
  • Siemens A.G.
  • General Electric(GE)
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • FUJIFILM SonoSite
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions
  • Molecubes

Methodology

Loading
LOADING...

Table Information